Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...

Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...

There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...

After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...

The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...

The neurovascular market, estimated at $4.2bn in 2024 by GlobalData, is becoming increasingly specialised and competitive.

Medtronic's agnostic approach to global challenges, including tariffs and AI, ensures success and innovation in healthcare ...

A series of important developments in the healthcare sector includes Medtronic adapting to tariff threats, Hims & Hers facing ...

The "U.S. Deep Brain Stimulation In Parkinson's Disease Market Size, Share & Trends Analysis Report By Product ...

The company, whose products range from insulin pumps to surgical robots, has been closely monitoring Trump's tariff plans due to its presence in Mexico.

Recent developments in the health sector include Pfizer appointing Patrizia Cavazzoni as Chief Medical Officer and Amgen ...

BioAsia 2025 panel discusses AI's impact on healthcare, emphasizing cybersecurity, diagnostics, therapeutics, patient ...